Literature DB >> 10688267

Cylindrospermopsin, a cyanobacterial alkaloid: evaluation of its toxicologic activity.

G R Shaw1, A A Seawright, M R Moore, P K Lam.   

Abstract

This paper describes the natural occurrence of the toxin, cylindrospermopsin, in two species of cyanobacteria found in Australia. The structure and chemical properties of this compound are described along with a nontoxic analog of cylindrospermopsin. The results of both intraperitoneal (IP) and oral dosing of mice show that hepatotoxicity is the main effect of cylindrospermopsin in vivo, but that a thrombohemorrhagic phenomenon is observed in a proportion of dosed animals. It has been shown that the toxin can be metabolized in vivo and that a bound metabolite occurs in the liver. Cytotoxicity experiments using cell cultures show that cylindrospermopsin is more cytotoxic to isolated rat liver hepatocytes than to other cell types. Risk assessment calculations show that guideline values for cylindrospernopsin in drinking water should lie in the low microgram per liter range.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688267     DOI: 10.1097/00007691-200002000-00019

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  18 in total

Review 1.  Natural products synthesis: enabling tools to penetrate Nature's secrets of biogenesis and biomechanism.

Authors:  Robert M Williams
Journal:  J Org Chem       Date:  2011-04-12       Impact factor: 4.354

2.  Impact of the toxicity of Cylindrospermopsis raciborskii (Woloszynska) Seenayya & Subba Raju on laboratory rats in vivo.

Authors:  Nevena B Đorđević; Sanja Lj Matić; Snežana B Simić; Snežana M Stanić; Vladimir B Mihailović; Nevena M Stanković; Vesna D Stanković; Andrija R Ćirić
Journal:  Environ Sci Pollut Res Int       Date:  2017-04-18       Impact factor: 4.223

3.  Effects of Chrysosporum (Aphanizomenon) ovalisporum extracts containing cylindrospermopsin on growth, photosynthetic capacity, and mineral content of carrots (Daucus carota).

Authors:  Remedios Guzmán-Guillén; Alexandre Campos; Joana Machado; Marisa Freitas; Joana Azevedo; Edgar Pinto; Agostinho Almeida; Ana M Cameán; Vitor Vasconcelos
Journal:  Ecotoxicology       Date:  2016-10-21       Impact factor: 2.823

4.  Acute effects of pure cylindrospermopsin on the activity and transcription of antioxidant enzymes in tilapia (Oreochromis niloticus) exposed by gavage.

Authors:  María Puerto; Angeles Jos; Silvia Pichardo; Daniel Gutiérrez-Praena; Ana M Cameán
Journal:  Ecotoxicology       Date:  2011-06-22       Impact factor: 2.823

Review 5.  Cylindrospermopsin: a decade of progress on bioaccumulation research.

Authors:  Susan Kinnear
Journal:  Mar Drugs       Date:  2010-03-09       Impact factor: 5.118

6.  Toxicity of cylindrospermopsin, and other apparent metabolites from Cylindrospermopsis raciborskii and Aphanizomenon ovalisporum, to the zebrafish (Danio rerio) embryo.

Authors:  John P Berry; Patrick D L Gibbs; Michael C Schmale; Martin L Saker
Journal:  Toxicon       Date:  2008-12-06       Impact factor: 3.033

7.  Health risk assessment for cyanobacterial toxins in seafood.

Authors:  Vanora Mulvenna; Katie Dale; Brian Priestly; Utz Mueller; Andrew Humpage; Glen Shaw; Graeme Allinson; Ian Falconer
Journal:  Int J Environ Res Public Health       Date:  2012-03-07       Impact factor: 3.390

8.  Cyanobacteria and Cyanotoxins Occurrence and Removal from Five High-Risk Conventional Treatment Drinking Water Plants.

Authors:  David C Szlag; James L Sinclair; Benjamin Southwell; Judy A Westrick
Journal:  Toxins (Basel)       Date:  2015-06-12       Impact factor: 4.546

9.  Health risk assessment of cyanobacterial (blue-green algal) toxins in drinking water.

Authors:  Ian R Falconer; Andrew R Humpage
Journal:  Int J Environ Res Public Health       Date:  2005-04       Impact factor: 3.390

10.  Double strand breaks and cell-cycle arrest induced by the cyanobacterial toxin cylindrospermopsin in HepG2 cells.

Authors:  Štraser Alja; Metka Filipič; Matjaž Novak; Bojana Žegura
Journal:  Mar Drugs       Date:  2013-08-21       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.